Europe In-Vitro Diagnostics Market Trends, Demand and Forecast 2034
- Bharat Jagtap
- 3 hours ago
- 5 min read
The Europe in-vitro diagnostics (IVD) market is witnessing robust growth driven by the increasing prevalence of infectious diseases, rising demand for early disease detection, and continuous advancements in diagnostic technologies. In-vitro diagnostic tests play a critical role in modern healthcare, supporting nearly 70% of clinical decision-making processes. Growing investments in research and development, increasing automation in laboratory workflows, and the adoption of advanced molecular and immunodiagnostic technologies are further accelerating market expansion across Europe. The region's well-established healthcare infrastructure and strong regulatory framework continue to support innovation and adoption of next-generation diagnostic solutions.
Market Size and Forecast
Europe is the second-largest regional market in the global in-vitro diagnostics industry and is projected to register a CAGR of 7.1% during the forecast period from 2023 to 2030. The global in-vitro diagnostics market is projected to grow from USD 94.67 billion in 2022 to USD 157.02 billion by 2030. Growth in Europe is being driven by increasing disease burden, technological advancements, growing laboratory testing volumes, and expanding healthcare investments.
For detailed market insights, visit the Europe In-vitro Diagnostics Market Report.
Why is the Europe In-vitro Diagnostics Market Growing Rapidly?
The growing incidence of infectious diseases, cancer, cardiovascular disorders, and chronic health conditions is significantly increasing demand for diagnostic testing across Europe. Healthcare providers are increasingly relying on advanced in-vitro diagnostic technologies to improve disease detection, treatment monitoring, and patient outcomes.
In addition, rising investments in research and development by leading diagnostic companies are resulting in innovative product launches and expanded testing capabilities. The increasing number of blood donations and laboratory tests performed annually across European countries further supports market growth. Germany alone collects approximately 2.4 million voluntary blood donations annually, while around 800 million tests are performed each year in England and Wales.
Key Market Trends Shaping Industry Growth
Growing Adoption of Automated Diagnostic Systems
Automation has become a major trend in the European IVD market. Diagnostic laboratories are increasingly implementing automated platforms that improve operational efficiency, reduce human errors, and increase testing capacity. Automated systems enable faster turnaround times and support growing testing volumes.
Rising Investments in Molecular and Immunodiagnostic Technologies
Healthcare providers and diagnostic companies are investing heavily in molecular diagnostics, immunodiagnostics, and advanced laboratory technologies to improve diagnostic accuracy and support personalized healthcare approaches.
Expansion of Point-of-Care Testing
Point-of-care diagnostics are gaining traction due to their ability to deliver rapid results closer to patients. The growing demand for decentralized testing solutions is creating significant opportunities for market participants across Europe.
Market Segmentation Analysis
Leading Product Type Segment
The reagents and consumables segment continues to account for a substantial share of the market due to recurring demand across diagnostic testing procedures. Increasing testing volumes and expanding disease screening programs are supporting segment growth.
Fastest Growing Product Type Segment
The instruments segment is witnessing strong growth as healthcare facilities invest in advanced automated systems and next-generation diagnostic platforms to improve laboratory productivity and testing efficiency.
Leading Technique Segment
Immunodiagnostics remains one of the most widely adopted diagnostic techniques due to its extensive application in infectious disease detection, oncology, and chronic disease monitoring.
Fastest Growing Technique Segment
Molecular diagnostics is expected to register significant growth due to increasing adoption for infectious disease testing, genetic analysis, and precision medicine applications.
Leading Setting Segment
Laboratories continue to dominate the market as the primary setting for diagnostic testing, supported by large testing volumes, advanced infrastructure, and increasing demand for specialized diagnostic services.
Leading End-user Segment
Clinical laboratories account for a major share of the market owing to favorable reimbursement frameworks, rising test volumes, and the growing importance of diagnostic services in disease management.
Regional Insights
Germany Leads the European Market
Germany remains one of the largest contributors to the European IVD market due to its advanced healthcare infrastructure, significant laboratory testing volumes, and strong presence of diagnostic manufacturers. The country collects approximately 2.4 million voluntary blood donations annually, highlighting the growing demand for diagnostic services.
United Kingdom Maintains Strong Market Position
The U.K. continues to play a crucial role in regional market growth, supported by extensive diagnostic testing activities and increasing adoption of advanced diagnostic technologies. Approximately 800 million tests are conducted annually in England and Wales, including 130 million hematology tests.
France, Italy, Spain, and Scandinavia Support Regional Expansion
Countries including France, Italy, Spain, and the Scandinavian region are witnessing increasing adoption of molecular diagnostics, clinical chemistry, and immunodiagnostic solutions. Government investments and healthcare modernization initiatives continue to support market growth.
Rest of Europe Shows Growing Diagnostic Adoption
The Rest of Europe region is experiencing increasing demand for advanced diagnostic technologies due to rising healthcare awareness, expanding laboratory infrastructure, and growing disease prevalence.
Competitive Landscape
The Europe in-vitro diagnostics market is highly competitive and characterized by the presence of leading global and regional diagnostic companies. Market participants are focusing on product innovation, regulatory approvals, strategic partnerships, and research investments to strengthen their market positions. Companies are also expanding distribution networks and introducing advanced automated systems to meet growing demand across the region.
Major Companies Operating in the Market Include:
bioMérieux SA
QIAGEN N.V.
F. Hoffmann-La Roche Ltd.
Siemens Healthineers AG
DiaSorin S.p.A.
Danaher Corporation
Bio-Rad Laboratories
Abbott
Becton Dickinson and Company
Quidel Corporation
Recent Industry Developments
bioMérieux Expanded Point-of-Care Diagnostics Portfolio
In February 2023, bioMérieux received U.S. FDA 510(k) clearance and CLIA certification for its BIOFIRE SPOTFIRE System and BIOFIRE SPOTFIRE Respiratory Panel, enabling broader adoption of point-of-care testing solutions.
bioMérieux Launched MONKEYPOX R-GENE PCR Kit
In February 2023, bioMérieux introduced the MONKEYPOX R-GENE PCR kit for qualitative virus detection in countries accepting Research Use Only (RUO) products.
QIAGEN Achieved IVDR Certification
In October 2022, QIAGEN received CE marking under the new European IVDR framework for its ipsogen JAK2 RGQ PCR kit and NeuMoDx systems and reagents.
Becton Dickinson Expanded Diagnostic Capabilities
In January 2022, Vitro S.A. announced the divestment of Cytognos, S.L. to Becton Dickinson and Company, strengthening BD's diagnostic product portfolio.
Future Outlook
The future of the Europe in-vitro diagnostics market remains highly promising as healthcare systems increasingly prioritize early disease detection, preventive care, and personalized medicine. Continued investments in automation, molecular diagnostics, artificial intelligence-enabled testing, and point-of-care solutions are expected to drive innovation across the industry. Although evolving regulatory requirements under the IVDR framework may present short-term challenges, they are likely to improve product quality and patient safety in the long run. Growing testing volumes, increasing healthcare expenditure, and technological advancements will continue to create substantial growth opportunities across Europe through 2030.
Request Sample Report
Request a sample report to gain comprehensive insights into market trends, competitive developments, technological innovations, regulatory changes, and future growth opportunities within the Europe in-vitro diagnostics market.
Explore More
Explore additional in-vitro diagnostics, molecular diagnostics, immunodiagnostics, clinical laboratory services, point-of-care testing, and healthcare technology market reports to identify emerging opportunities and strategic growth areas across the global healthcare industry.
Comments